Therapeutic agents for the treatment of migraine
    6.
    发明授权
    Therapeutic agents for the treatment of migraine 有权
    用于治疗偏头痛的治疗剂

    公开(公告)号:US07772244B2

    公开(公告)日:2010-08-10

    申请号:US11091429

    申请日:2005-03-28

    CPC分类号: C07D401/14

    摘要: The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

    摘要翻译: 本发明涉及作为降钙素基因相关肽受体(“CGRP受体”)拮抗剂的式(I)化合物,包含它们的药物组合物,鉴定它们的方法,使用它们的治疗方法及其在治疗治疗中的用途 神经源性血管舒张,神经源性炎症,偏头痛和其他头痛,热损伤,循环休克,与更年期相关的潮红,气道炎症性疾病如哮喘和慢性阻塞性肺疾病(COPD)以及其他治疗可以通过 CGRP受体的拮抗作用。